LivaNova PLC Loss Contingency, Estimate of Possible Loss
LivaNova PLC (LIVN) had Loss Contingency, Estimate of Possible Loss of $633.10 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2024-02-29
- 2019-03-05: Loss Contingency, Estimate of Possible Loss 572.10M EUR.
EUR
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2019-03-05 | 572.10M EUR 10-K · filed 2024-02-29 |
USD
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2023-12-31 | $633.10M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |